Investors: Press Releases

Press Releases

July 14, 2022
NexImmune Announces IND Clearance by the US FDA for NEXI-003 for the Treatment of HPV-Related Cancers
May 12, 2022
NexImmune Reports First Quarter 2022 Financial Results and Provides Business Updates
May 10, 2022
NexImmune, Yale, and JDRF Enter into Research Partnership for Type 1 Diabetes
May 10, 2022
NexImmune Announces Appointment of Dr. Leena Gandhi to its Board of Directors
April 26, 2022
NexImmune Announces Preclinical Research Collaboration with Columbia University Irving Medical Center’s Herbert Irving Comprehensive Cancer Center
April 14, 2022
NexImmune Promotes Mathias Oelke, Ph.D., To Chief Scientific Officer
March 17, 2022
NexImmune and Zephyr AI Announce a Strategic Partnership in Oncology for Target Discovery and Validation
March 14, 2022
NexImmune Announces Melanoma Research Collaboration with NYU Langone’s Perlmutter Cancer Center
March 10, 2022
NexImmune to Present at the Barclays 2022 Global Healthcare Conference
March 9, 2022
NexImmune Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
Displaying 1 - 10 of 55